Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma
Clinical trial NCT06008106 · RECRUITING
Trial details
- NCT number
- NCT06008106
- Sponsor
- Shanghai Kechow Pharma, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-02
- Primary completion
- 2027-09-22
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.